Assessing both central adiposity and inflammatory burden may aid in identifying high-risk CKD patients and guide clinical strategies for improving long-term outcomes.
Abstract
The weight-adjusted waist index (WWI), a recently proposed marker reflecting central fat distribution independent of body weight, has emerged as a potential indicator of metabolic and cardiovascular risk. Considering the high burden of inflammation and metabolic disturbance in chronic kidney disease (CKD), we examined whether elevated WWI is associated with all-cause and cardiovascular disease (CVD) mortality among CKD patients and whether systemic inflammation, assessed by the neutrophil-to-lymphocyte ratio (NLR), mediates this relationship. Data were obtained from the National Health and Nutrition Examination Survey 1999 to 2018 cycles. WWI was calculated based on anthropometric measurements. Weighted multivariate Cox proportional hazards models were applied to examine the associations of WWI with mortality. Robustness was verified through WWI quartile-based survival curves and subgroup analyses. Mediation analysis was used to evaluate the indirect effect of NLR on the WWI–mortality relationship. A total of 5582 CKD participants were included. WWI levels were significantly and independently associated with increased risks of all-cause mortality (adjusted hazard ratio = 1.17, 95% confidence interval (CI): 1.09–1.26, P < .001) and CVD mortality (adjusted hazard ratio = 1.24, 95% CI: 1.09–1.41, P = .001). WWI showed a linear positive relationship with both outcomes (nonlinearity P > .05). Mediation analysis indicated that NLR exerted a modest but significant indirect effect on all-cause mortality (β = −9.94, 95% CI:−20.90–−2.85, P < .001), explaining 6.66% of the total effect. Elevated WWI was independently associated with higher risks of all-cause and CVD mortality in CKD. NLR partially mediated these associations. Therefore, assessing both central adiposity and inflammatory burden may aid in identifying high-risk CKD patients and guide clinical strategies for improving long-term outcomes.
Abstract Central adiposity is a key driver of cardiovascular risk in chronic kidney disease (CKD), yet conventional obesity indices incompletely capture this risk. The weight-adjusted waist index (WWI) is an emerging anthropometric measure that integrates abdominal adiposity independent of body weight, but its prognost...
Weight-adjusted waist index was the strongest independent predictor of all-cause and cardiovascular mortality among 4 adiposity indices, and its linear dose-response relationship, consistency across subgroups, and calculability from waist circumference and body weight alone support its use as a practical alternative to...
Ercan Kahraman, Şirin Çetin, Ozkan Ozler· Anatolian journal of cardiol...· 0 citations
Cardiovascular-kidney-metabolic (CKM) syndrome integrates metabolic abnormalities, chronic kidney disease, and cardiovascular disease (CVD), with stages 0–3 representing a critical window for primary prevention. Whether the Chinese visceral adiposity index (CVAI) adds predictive value for CVD in this population r...
Long Feng, Geng Yang, He-Song Zeng et al.· Cardiovascular Diabetology· 0 citations
TyG-FI, which captures both metabolic dysfunction and physiological frailty, showed stronger associations with advanced CKM syndrome, prevalent CMM, and mortality than most surrogate insulin resistance indices, and may offer a pragmatic tool for early mortality risk stratification in individuals with high cardiometabol...
Kang Liu, Jia-Yuan Zhang, Hui He et al.· Cardiovascular Diabetology· 0 citations
ObjectiveCoronary heart disease (CHD) constitutes a primary cause of morbidity and mortality worldwide. The estimated glucose disposal rate (eGDR) serves as a surrogate marker of insulin resistance, whereas the albumin-bilirubin (ALBI) score reflects liver-related systemic status. However, their joint associations with...
Y. Lei, Guang Li, Qiu-Yue Huang et al.· Science in progress· 0 citations
It is suggested that TyG-derived inflammatory indices may hold clinical value in predicting mortality risk among patients with CKD, and in the first systematic comparison of multiple such indices, TyG-MLR emerged as the best-performing indicator, although its discriminative performance was moderate.
Rong-Wen Lin, Hui-Juan Zhao, Bo Wu· Science in progress· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.